NTRK1 and neoplasm: Authors suggested that this co-expression might be a link of the microenvironment to the tropomyosin receptor kinase A (TrkA)-positive tumor cells, representing a critical mechanism for tumor growth and lack of response to anti-PD-1/L1 treatment, requiring to be investigated in further studies (91).